The obesity preventive effects were not based on differences in food intake but on significant immune-modulating benefits, including decreased M1 ATM, and inhibition of TNF-α and NF-κB. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.